S. Nematollahi, E. Ayubi, Y. Moradi, A. Almasi-Hashiani, Kamyar Mansori, E. Jenabi, S. Khazaei
{"title":"伊朗高危人群中HIV感染的流行:一项系统回顾和荟萃分析","authors":"S. Nematollahi, E. Ayubi, Y. Moradi, A. Almasi-Hashiani, Kamyar Mansori, E. Jenabi, S. Khazaei","doi":"10.5114/HIVAR.2021.105107","DOIUrl":null,"url":null,"abstract":"Introduction: In Iran, data relating to an updated prevalence of human immunodeficiency virus (HIV) infection among high-risk groups are lacking. Therefore, this study aimed to determine the prevalence of HIV infection among high-risk groups in Iran through meta-analyses. Material and methods: Electronic scientific databases, including PubMed, SCOPUS, and Web of Knowledge were explored to identify relevant studies. Random effect model was used to estimate the pooled prevalence. Results: A total of 1,113 records were identified in initial search, out of which 43 reports were finally included in the study. The estimated overall prevalence among high-risk groups was 0.06%, which ranged from 0 among drug addict prisoners in the North to 0.2 among drug addicts in the South of Iran. Conclusions: Prevalence of HIV among high-risk groups in Iran is relatively low. The prevalence of HIV in high-risk groups in different parts of Iran has a different pattern. Due to significant prevalence of HIV in injecting drug users compared to other high-risk groups, there is a need to pay serious attention to this high-risk group and adopt preventive strategies. HIV AIDS Rev 2021; 20, 1: 1-9 DOI: https://doi.org/10.5114/hivar.2021.105107","PeriodicalId":53943,"journal":{"name":"HIV & AIDS Review","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of HIV infection among high-risk groups in Iran: a systematic review and meta-analysis\",\"authors\":\"S. Nematollahi, E. Ayubi, Y. Moradi, A. Almasi-Hashiani, Kamyar Mansori, E. Jenabi, S. Khazaei\",\"doi\":\"10.5114/HIVAR.2021.105107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: In Iran, data relating to an updated prevalence of human immunodeficiency virus (HIV) infection among high-risk groups are lacking. Therefore, this study aimed to determine the prevalence of HIV infection among high-risk groups in Iran through meta-analyses. Material and methods: Electronic scientific databases, including PubMed, SCOPUS, and Web of Knowledge were explored to identify relevant studies. Random effect model was used to estimate the pooled prevalence. Results: A total of 1,113 records were identified in initial search, out of which 43 reports were finally included in the study. The estimated overall prevalence among high-risk groups was 0.06%, which ranged from 0 among drug addict prisoners in the North to 0.2 among drug addicts in the South of Iran. Conclusions: Prevalence of HIV among high-risk groups in Iran is relatively low. The prevalence of HIV in high-risk groups in different parts of Iran has a different pattern. Due to significant prevalence of HIV in injecting drug users compared to other high-risk groups, there is a need to pay serious attention to this high-risk group and adopt preventive strategies. HIV AIDS Rev 2021; 20, 1: 1-9 DOI: https://doi.org/10.5114/hivar.2021.105107\",\"PeriodicalId\":53943,\"journal\":{\"name\":\"HIV & AIDS Review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV & AIDS Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/HIVAR.2021.105107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV & AIDS Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/HIVAR.2021.105107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
在伊朗,缺乏有关高危人群中人类免疫缺陷病毒(HIV)感染流行率的最新数据。因此,本研究旨在通过荟萃分析确定伊朗高危人群中HIV感染的流行情况。材料与方法:检索PubMed、SCOPUS、Web of Knowledge等电子科学数据库,查找相关研究。采用随机效应模型估计合并患病率。结果:初步检索共识别1113条记录,其中43例报告最终纳入研究。估计高危人群的总体患病率为0.06%,其范围从伊朗北部吸毒囚犯的0到伊朗南部吸毒成瘾者的0.2。结论:伊朗高危人群的HIV患病率相对较低。在伊朗不同地区,艾滋病毒在高危人群中的流行情况有不同的模式。由于与其他高危人群相比,注射吸毒者中艾滋病毒的流行率很高,因此有必要认真关注这一高危群体并采取预防战略。HIV / AIDS Rev 2021;DOI: https://doi.org/10.5114/hivar.2021.105107
Prevalence of HIV infection among high-risk groups in Iran: a systematic review and meta-analysis
Introduction: In Iran, data relating to an updated prevalence of human immunodeficiency virus (HIV) infection among high-risk groups are lacking. Therefore, this study aimed to determine the prevalence of HIV infection among high-risk groups in Iran through meta-analyses. Material and methods: Electronic scientific databases, including PubMed, SCOPUS, and Web of Knowledge were explored to identify relevant studies. Random effect model was used to estimate the pooled prevalence. Results: A total of 1,113 records were identified in initial search, out of which 43 reports were finally included in the study. The estimated overall prevalence among high-risk groups was 0.06%, which ranged from 0 among drug addict prisoners in the North to 0.2 among drug addicts in the South of Iran. Conclusions: Prevalence of HIV among high-risk groups in Iran is relatively low. The prevalence of HIV in high-risk groups in different parts of Iran has a different pattern. Due to significant prevalence of HIV in injecting drug users compared to other high-risk groups, there is a need to pay serious attention to this high-risk group and adopt preventive strategies. HIV AIDS Rev 2021; 20, 1: 1-9 DOI: https://doi.org/10.5114/hivar.2021.105107